Bharat Biotech International Ltd. -- to develop a homegrown vaccine in record time. Since then the company has been buffeted by controversies ranging from unrealistic government schedules to sporadic reports of adverse reactions.
Matters came to a head last month after the government approved its shot before the completion of final human trials.That fueled a revolt across the breadth of India with many at the frontlines of the pandemic -- particularly health-care workers -- refusing the company’s injection.